NSEOutcome of Board Meeting4d ago · 8 Aug 2026, 03:15 pm

Outcome of Board Meeting

Medi Assist Healthcare Services Limited · MEDIASSIST

✦ AI SummaryResults

Medi Assist Healthcare Services Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026. The Board of Directors have approved unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, and intimated the Annual General Meeting and Record Date for the purpose of payment of final dividend for the financial year 2025-26. Additionally, the Board has approved the appointment of Mr. Gaurav Bhatnagar as Senior Managerial Personnel and the change in designation of Dr. Vikram Jit Singh Chhatwal from Whole-Time Director to Non-Executive, Non-Independent Director.

Analysis Scores

Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medi Assist Healthcare Services Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026.

Attachments (1)

📄

MEDIASSIST_08082026151408_1MAHSOutcomeofBMFS.pdf

pdf

Download →
View document text
August 08, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: MEDIASSIST Scrip Code: 544088 Dear Sir/ Madam, Subject: Outcome of the Board Meeting – August 08, 2026 The Board of Directors of Medi Assist Healthcare Services Limited (the ‘Company’) in their meeting held today i.e., August 08, 2026, have inter-alia, approved the following: 1) Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 Approved unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. Copy of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 along with Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith. 2) Intimation of Annual General Meeting and Record Date for the purpose of payment of final dividend for the financial year 2025-26 The 26th Annual General Meeting (‘AGM’) of the Company shall be held on Thursday, September 24, 2026 at 10:30 AM (IST) through Video Conferencing/ Other Audio-Visual Means in compliance with applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The Board of Directors has fixed Friday, September 11, 2026 as the Record Date for the purpose of determining the shareholders eligible to receive final dividend of Rs. 2/- per equity share on the face value of Rs. 5/- each for the financial year 2025-26 in terms of Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’). Dividend shall be paid, subject to deduction of tax at source, within 30 days from the date of shareholders’ approval at the ensuing AGM of the Company. 3) Appointment of Mr. Gaurav Bhatnagar as Senior Managerial Personnel in line with SEBI Listing Regulations Based on the recommendation of Nomination & Remuneration Committee, the Board of Directors of the Company have approved designation of Mr. Gaurav Bhatnagar as Senior Managerial Personnel of the Company effective August 08, 2026. He has joined Medi Assist Insurance TPA Private Limited, a subsidiary of the Company as Chief TPA Officer. Disclosure under Regulation 30 of the SEBI Listing Regulations for the said matter, as applicable, is being filed separately. 4) Change in designation of Dr. Vikram Jit Singh Chhatwal from Whole-Time Director to Non-Executive, Non-Independent Director of the Company The Board of Directors of the Company have considered separation of the roles of Chairman and executive management to better align the Company’s governance framework, Board leadership and succession planning. In light of the foregoing, Dr. Vikram Jit Singh Chhatwal (DIN: 01606329) has proposed to demit the office of Whole-Time Director, and to continue on the Board as a Non-Executive, Non-Independent Director and Chairman, liable to retire by rotation, with effect from the close of business hours of August 08, 2026. Consequently, he shall cease to be a Key Managerial Personnel of the Company with effect from the said date. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the aforesaid change in designation, subject to approval of the members of the Company and such other approvals as may be required. Disclosure under Regulation 30 of the SEBI Listing Regulations for the said matter, as applicable, is being filed separately. The Board Meeting commenced at 1.45 p.m. (IST) and concluded at 3.00 p.m. (IST). The trading window for dealing in shares of the Company is closed from July 01, 2026 till August 10, 2026. This outcome shall also be made available on the Company’s website at www.mediassist.in You are requested to take the same on record. Yours faithfully, For Medi Assist Healthcare Services Limited Rashmi B V Company Secretary & Compliance Officer ICSI Membership No: A38729 Encl.: Unaudited financial results along with Limited Review Report . SV Tower, No. 27, Floor 4 M S K A & ASSOC]ateS LLP 80 Feet Road, 6th Block, Koramangala (Formerly known as M S K A & Associates) ARSI 6000 MDA Chartered Accountants Independent Auditor’s Review Report on standalone unaudited financial results of Medi Assist Healthcare Services Limited for the quarter pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Medi Assist Healthcare Services Limited (hereinafter referred to as ‘the Company’) for the quarter ended June 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Company’s Management and has been approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Page 1 of 2 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 | LLPIN: ACT-3789 Ahmedabad | Chandigarh | Chennai | Coimbatore | Goa | Gurugram | Hyderabad | HKochi | Kolkata | Mumbai | Pune www.mska.in MSKA & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants 5. Emphasis of matter We draw attention to Note 7 to the accompanying Statement which describes that search and seizure operation was carried out by the Directorate of Enforcement at certain offices of a wholly owned subsidiary and the management's assessment thereof about the consequent impact on the Statement. Our conclusion is not modified in respect of this matter. For M S K A & Associates LLP (Formerly known as M S K A & Associates) Chartered Accountants ICAI Firm Registration No.105047W/W101187 Pankaj S Bhauwala Partner Membership No.: 233552 UDIN: [Showing first 8,000 characters — download PDF for full document]